HL Launches Telepharmacy Platform via iCare Health

Product / TechM&A · Partnership
โดย Kaohoon·TH·Read original
Summary · why it matters

Healthlead Public Company Limited, or HL, is preparing to launch its Telepharmacy platform through an application operated by iCare Health Company Limited, aiming to elevate pharmacies into the digital era. Patients will be able to consult pharmacists remotely and receive medications delivered to their homes, in accordance with regulations permitted by the Food and Drug Administration (FDA). Additionally, HL has partnered with pharmaceutical delivery service CERO Win to support logistics, enhancing service standards. This development marks a significant step in integrating technology into the Health & Wellness business, with expectations for it to serve as a growth engine driving revenue in 2026 to a new record high, in line with targets.

Impact on stocks 1

Health Care · 1 stocks
Healthlead Public Company Limited
HL
▲ PositiveTechnologyrelevance

HL is launching a Telepharmacy platform via iCare Health, integrating technology into its Health & Wellness business as a 2026 growth driver.

Off-coverage companies 1

CERO WinPrivate± Mixed
relevance